Company Search:
Advanced Search
Sponsored Links
RepliCel Life Sciences Inc Company Snapshot
RepliCel Life Sciences Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares RepliCel Life Sciences Inc with three other companies in this sector in Canada: Medicure Inc (2013 sales of 2.60 million Canadian Dollars [US$1.95 million] of which 100% was Pharmaceutical Prod), Ceapro Inc (6.52 million Canadian Dollars [US$4.90 million] ), and Sophiris Bio Incorporation (5.17 million Canadian Dollars [US$3.88 million] of which 100% was Pharmaceutical Products).

Sales Analysis.
  Stock Performance Chart for RepliCel Life Sciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): .37
(Figures in Canadian Dollars)
1 Week -2.6%   13 Weeks -16.9%  
4 Weeks -3.9%   52 Weeks -22.9%  
RepliCel Life Sciences Inc Key Data:
  Ticker: RP Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2013 Sales 4,120,400
(Year Ending Jan 2014).
Employees: 4
  Currency: Canadian Dollars Market Cap: 9,916,179
  Fiscal Yr Ends: December Shares Outstanding: 26,800,484
  Share Type: Common Closely Held Shares: 8,066,747
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.